The AHA released a statement for malnutrition and cachexia in patients with cardiac conditions, and discuss clinical strategies for support and management.

The ACC and AHA released updated guidelines for the management of dyslipidemia to reduce risk for atherosclerotic cardiovascular disease.

The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use disorders (SUDs).

For patients with prostate cancer, concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs does not increase risks for thrombosis or bleeding.

Stroke and traumatic brain injury (TBI) symptoms and signs vary. TBI includes light, noise sensitivity; stroke presents with facial drooping.

During the COVID-19 pandemic, rates of new stimulant prescriptions dispensed to adults accelerated rapidly, according to a study published online March 9 in CMA ...

The FDA accepts the NDA for lorundrostat, a selective aldosterone synthase inhibitor, for adults with uncontrolled or resistant hypertension.

Telemedicine visits may cost less than in-person care without increasing subsequent short-term health care use.

Dr Vinay Prasad, who leads the FDA division that oversees vaccines and complex medical treatments, is leaving the agency at the end of April.

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Respiratory sarcopenia, defined by low diaphragm thickness and reduced FVC, is associated with increased 2-year mortality in HF.

Low income and high social deprivation are independently associated with adverse clinical outcomes in patients with HCM.